Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of IREB2 mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of IREB2 mRNA | affects expression | 21346803
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of IREB2 mRNA | affects expression | 17562736
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of IREB2 mRNA | affects expression | 16483693
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of IREB2 mRNA | decreases expression | 19150397
|
D003676 |
Deferoxamine |
Deferoxamine results in increased activity of IREB2 protein | increases activity | 11054110
|
D003676 |
Deferoxamine |
Deferoxamine results in increased expression of and results in increased activity of IREB2 protein | increases activity|increases expression | 16568477
|
D003676 |
Deferoxamine |
Deferoxamine results in increased expression of IREB2 protein | increases expression | 17469137
|
D004317 |
Doxorubicin |
Doxorubicin results in decreased activity of IREB2 protein | decreases activity | 16770644
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of IREB2 mRNA | increases expression | 17942748
|
C013531 |
ferric ammonium citrate |
ferric ammonium citrate results in decreased activity of IREB2 protein | decreases activity | 11054110
|
C013531 |
ferric ammonium citrate |
ferric ammonium citrate results in decreased expression of IREB2 protein | decreases expression | 17469137
|
D005419 |
Flavonoids |
Flavonoids results in decreased expression of IREB2 mRNA | decreases expression | 18035473
|
D005472 |
Fluorouracil |
Fluorouracil results in increased expression of IREB2 mRNA | increases expression | 16584549
|
D006427 |
Hemin |
Hemin results in decreased expression of and results in decreased activity of IREB2 protein | decreases activity|decreases expression | 16568477
|
D007501 |
Iron |
IREB2 protein affects the metabolism of Iron | affects metabolic processing | 17194590
|
D008070 |
Lipopolysaccharides |
[Lipopolysaccharides co-treated with IFNG protein] results in decreased activity of IREB2 protein | affects cotreatment|decreases activity | 11054110
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in decreased activity of IREB2 protein | decreases activity | 11054110
|
D008345 |
Manganese |
Manganese results in decreased activity of IREB2 protein | decreases activity | 16568477
|
D008345 |
Manganese |
Manganese results in increased expression of IREB2 protein | increases expression | 17469137
|
C025340 |
manganese chloride |
manganese chloride results in decreased activity of IREB2 protein | decreases activity | 16568477
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of IREB2 mRNA | increases expression | 17426115
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of IREB2 mRNA | decreases expression | 18163543
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.81 | 11752688 15322242 14514962 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.52 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.91 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
8.90 | 18653653 11850527 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
8.90 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
7.06 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
7.06 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
7.06 | 17638652 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
9.78 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
9.78 | 16835633 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.50 | 21441931 |
MESH:D019896 |
alpha 1-Antitrypsin Deficiency |
|
Iron |
5.62 | 16640825 |
MESH:D000544 |
Alzheimer Disease |
|
Iron |
2.99 | 16640825 16563566 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
14.67 | 16511603 17963324 15504547 |
MESH:D000740 |
Anemia |
|
Iron |
14.67 | 16434484 16566752 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
14.67 | 11748828 |
MESH:D018798 |
Anemia, Iron-Deficiency |
|
Iron |
4.61 | 17162259 17163184 16569441 17147795 17375513 |
MESH:D000756 |
Anemia, Sideroblastic |
|
Iron |
17.67 | 16910769 |
MESH:D000756 |
Anemia, Sideroblastic |
|
Manganese |
17.67 | 16910769 |
MESH:D000756 |
Anemia, Sideroblastic |
|
manganese chloride |
17.67 | 16910769 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.81 | 10982225 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Iron |
4.33 | 16604332 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.42 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.64 | 15885639 |
MESH:D001260 |
Ataxia Telangiectasia |
|
Iron |
5.41 | 15336622 |
MESH:D050197 |
Atherosclerosis |
|
Iron |
3.68 | 16640825 16632123 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
2.14 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Iron |
2.14 | 17352947 |
MESH:D001424 |
Bacterial Infections |
|
Iron |
5.16 | 16640825 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
8.63 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.63 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.76 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.73 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.67 | 14601052 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.77 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Deferoxamine |
2.03 | 15993339 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
2.03 | 17983394 15136595 15692762 15939500 16115903 16595493 16826403 16096432 16322301 18695136 16935488 18628466 15634643 16264153 18382427 19526202 15668708 11325840 17426702 15993339 17369602 18234424 15994142 15567936 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
2.03 | 15136595 16110121 19217205 18608205 16557594 16595493 18357371 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.03 | 20435547 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
12.26 | 16051944 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
12.26 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
8.06 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
8.06 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
8.80 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
8.80 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
8.80 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
8.80 | 16234567 18059187 16023760 17876044 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
8.80 | 16799960 17045692 17088986 16332177 17971768 18930000 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
6.61 | 16201981 1485588 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
6.61 | 18695887 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
4.81 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
4.81 | 16757204 17066447 18986760 16280240 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.34 | 18850075 18670907 16120746 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
8.07 | 17974986 16364871 16612575 15811867 16952015 17519947 16242529 16269455 16455267 16109756 17924179 18627295 16278810 17329180 17382496 15476868 17928571 17131338 17007740 15505089 15792986 17308081 16731534 16651473 17351982 |
MESH:D009202 |
Cardiomyopathies |
|
Iron |
8.07 | 16640825 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
6.14 | 16243910 17334414 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Iron |
6.14 | 16604332 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.55 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
6.54 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
6.54 | 20889678 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.12 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
7.63 | 17110522 16919318 15861022 16105132 17333356 17681005 11677210 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.63 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.08 | 16354765 8697196 15668235 15340226 12621046 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
4.05 | 17725105 17169374 16510598 17016597 15001691 16340194 17287894 18772588 17172411 17018589 |
MESH:D003110 |
Colonic Neoplasms |
|
Iron |
4.05 | 16640825 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.64 | 18259882 18802399 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
2.64 | 18802399 18288408 14970324 16303861 18448328 15148649 15289873 16282729 17255274 18509181 18949393 17401013 17594712 17695437 17016601 18383874 16391804 17454858 17094418 16331619 20501625 16524972 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.02 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.25 | 10048152 20055451 15322242 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
10.76 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
10.76 | 18551238 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.76 | 16733453 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.40 | 18249437 |
MESH:D003920 |
Diabetes Mellitus |
|
Iron |
4.41 | 16640825 16604332 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Iron |
3.34 | 16506275 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Iron |
4.52 | 16506275 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.52 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
11.87 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
11.87 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
11.87 | 12540782 14725611 11743745 17906064 11529661 16781746 11739529 16227642 12594235 16109766 10663392 12705907 15619225 14986274 10774834 17522070 17562736 19739265 19923254 11834606 16485898 18071297 16393943 16081117 18713872 11461765 12392966 19416960 19420014 15968718 19370779 11421492 12153990 12958197 19164858 10915739 2444490 19085960 14550746 16177239 11287661 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
11.87 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
11.87 | 20420201 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.07 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
8.00 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
8.00 | 11462148 |
MESH:D004487 |
Edema |
|
pirinixic acid |
6.40 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.40 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.87 | 16714409 15322242 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.15 | 12538720 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
3.42 | 17359293 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.98 | 10568697 9294722 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.13 | 18037988 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
4.36 | 15328337 15821434 17637181 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.47 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
4.47 | 17638652 15173087 16481741 16337965 16785472 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.98 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
12.93 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Iron |
12.93 | 16640825 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
12.93 | 20131406 19236843 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.42 | 11858732 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
3.97 | 9205823 11852909 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.55 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
2.91 | 20067830 |
MESH:D005621 |
Friedreich Ataxia |
|
Iron |
5.39 | 16604332 16640825 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.65 | 16983495 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
7.48 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Manganese |
7.48 | 17043766 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
2.85 | 16145905 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.57 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
7.82 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
7.82 | 15162350 18337622 15102660 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.31 | 11294989 10048152 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.45 | 12587719 14766674 17888722 16244372 16707910 16879835 18674790 18006777 16330681 16495754 16244371 17875725 16144979 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
6.96 | 17481944 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
6.96 | 20558911 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.86 | 15692506 |
MESH:D006432 |
Hemochromatosis |
|
Iron |
4.46 | 16604332 16640825 17053826 16574947 17236123 17255318 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
4.34 | 16366002 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.29 | 11000095 |
MESH:D006486 |
Hemosiderosis |
|
Iron |
5.19 | 16604332 |
MESH:D006525 |
Hepatitis, Viral, Human |
|
Iron |
5.44 | 16640825 |
MESH:D006527 |
Hepatolenticular Degeneration |
|
Iron |
4.90 | 17182432 |
MESH:D006529 |
Hepatomegaly |
|
Iron |
14.27 | 16890145 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
14.27 | 18467677 16221962 19176532 19772884 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
14.27 | 12621046 16120746 15340226 |
MESH:D015658 |
HIV Infections |
|
Iron |
3.65 | 16597321 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.37 | 17606976 18501091 15147373 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.02 | 16959395 15340226 16354765 8697196 18606429 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.66 | 16870215 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.14 | 20558911 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.89 | 18670907 18850075 |
MESH:D007006 |
Hypogonadism |
|
Iron |
4.37 | 16640825 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.77 | 16569931 16945680 |
MESH:D007037 |
Hypothyroidism |
|
Iron |
5.04 | 16640825 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.42 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.46 | 17937319 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
8.24 | 17296493 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
8.24 | 9205823 17237260 17255318 12878042 17963957 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
8.24 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.60 | 16306350 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Iron |
11.46 | 17163184 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
11.46 | 17255318 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.29 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
5.97 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
5.97 | 16775033 15699352 15369732 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.11 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
12.23 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
12.23 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
12.23 | 16985049 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.13 | 16085563 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Deferoxamine |
3.51 | 20368581 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
4.66 | 15821434 |
MESH:D020961 |
Lewy Body Disease |
|
Iron |
5.39 | 16563566 |
MESH:D008103 |
Liver Cirrhosis |
|
Iron |
3.70 | 16640825 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
4.92 | 16439617 16595196 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
4.92 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
4.92 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
4.92 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
4.53 | 12969438 11587558 19460945 16611625 19014921 12587719 19784758 16610002 |
MESH:D008107 |
Liver Diseases |
|
Hemin |
4.53 | 17173083 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Iron |
4.97 | 17207112 16737972 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.20 | 16871587 17185352 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
14.08 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
14.08 | 15113037 17045692 18383874 16603448 |
MESH:D008113 |
Liver Neoplasms |
|
Iron |
14.08 | 16640825 20302851 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
14.08 | 20007298 15890375 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
14.08 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
9.68 | 2876784 6135515 2876786 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
9.68 | 16842330 17085340 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
9.68 | 12151625 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
3.97 | 21114838 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
4.86 | 17418594 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
4.86 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Iron |
4.86 | 16640825 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
4.86 | 11884234 19555203 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.76 | 15086387 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.43 | 16098063 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.75 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.53 | 15621674 |
MESH:D008268 |
Macular Degeneration |
|
Iron |
3.96 | 16640825 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
3.00 | 15458769 |
MESH:D020149 |
Manganese Poisoning |
|
Manganese |
5.49 | 16568477 16551646 19453300 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
2.28 | 16827129 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.53 | 19513568 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
3.04 | 17638057 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.46 | 15792986 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
3.60 | 16757204 18986760 |
MESH:D009069 |
Movement Disorders |
|
Manganese |
4.97 | 16551646 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.75 | 17415656 |
MESH:D020528 |
Multiple Sclerosis, Chronic Progressive |
|
Iron |
5.64 | 17086897 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.47 | 16239165 |
MESH:D009181 |
Mycoses |
|
Iron |
5.44 | 16640825 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
5.65 | 19429709 15857846 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
5.65 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Iron |
9.05 | 16604332 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
9.05 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Iron |
8.50 | 16604332 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
8.50 | 16411023 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
10.23 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
10.23 | 7678174 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
2.93 | 18259882 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
4.91 | 16928823 18600527 18239605 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
4.91 | 17405874 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.73 | 16899518 16636307 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
9.62 | 15640375 16889571 |
MESH:D009404 |
Nephrotic Syndrome |
|
Iron |
9.62 | 17178036 |
MESH:D009410 |
Nerve Degeneration |
|
Manganese |
4.24 | 16551646 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.17 | 14600291 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.24 | 15555623 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
8.39 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Iron |
8.39 | 16604332 17296847 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.41 | 16436463 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.80 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
8.75 | 12819281 16049721 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
8.75 | 16049721 |
MESH:D010003 |
Osteoarthritis |
|
Iron |
3.94 | 16640825 |
MESH:D010024 |
Osteoporosis |
|
Iron |
3.83 | 16640825 16648989 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.08 | 15930896 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.35 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
2.65 | 16500647 19003803 15113037 16929163 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.65 | 11578682 |
MESH:D010212 |
Papilloma |
|
Iron |
4.44 | 12065085 |
MESH:D020447 |
Parasomnias |
|
Iron |
5.99 | 17352947 |
MESH:D010300 |
Parkinson Disease |
|
Iron |
5.86 | 16563566 16640825 |
MESH:D010300 |
Parkinson Disease |
|
Manganese |
5.86 | 11181820 |
MESH:D020734 |
Parkinsonian Disorders |
|
Manganese |
4.43 | 16140633 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.22 | 12520081 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.13 | 17983394 |
MESH:D010900 |
Pituitary Diseases |
|
Iron |
5.64 | 16604332 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.13 | 17638057 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
4.52 | 12224865 11605937 |
MESH:D011041 |
Poisoning |
|
Iron |
4.25 | 16604332 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Iron |
10.89 | 16640825 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
10.89 | 18163543 |
MESH:D011225 |
Pre-Eclampsia |
|
Iron |
4.39 | 16640825 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.16 | 11896295 11118676 11222880 11399792 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
3.46 | 16888761 16729912 15749863 18437689 16868541 15897917 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
3.46 | 18626508 19082440 |
MESH:D011528 |
Protozoan Infections |
|
Iron |
5.99 | 16640825 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.28 | 15861022 16919318 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
3.97 | 15538739 18722050 16160472 18286688 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.18 | 17922066 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.36 | 19058328 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.70 | 10835634 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.80 | 18990726 |
MESH:D012148 |
Restless Legs Syndrome |
|
Iron |
4.51 | 16930377 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.95 | 15625365 17203757 16767912 15675481 18313854 17710206 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.20 | 14601052 16326096 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.75 | 17846226 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
5.77 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
5.77 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
9.46 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Iron |
9.46 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
9.46 | 16192470 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.53 | 15625365 17203757 16767912 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.91 | 16709447 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
2.00 | 17522103 16951190 18396642 19084572 16424979 17498489 18567086 19015929 15786421 17172411 |
MESH:D013398 |
Sudden Infant Death |
|
Iron |
5.41 | 16640825 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
4.12 | 15821434 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.58 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.11 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.87 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
3.33 | 16010429 17909728 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
3.95 | 16280240 |
MESH:D014376 |
Tuberculosis |
|
Iron |
4.06 | 16597321 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
8.25 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
8.25 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
8.25 | 17653716 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
11.87 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
11.87 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.94 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
3.84 | 16803524 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.26 | 14692618 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.57 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.50 | 14671159 15869587 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.18 | 17334414 16364871 17678736 17638931 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.22 | 15886252 |